A new AI-powered technology, developed by Columbia University, is now locating sperm cells in men previously deemed infertile, drawing hundreds of hopeful couples from "all around the world" to its waiting list. This technological intervention offers a path to biological children for those unable to conceive naturally, raising questions about the increasing reliance on advanced systems to reshape fundamental human processes.
The Star (Sperm Track and Recovery) system utilizes artificial intelligence to identify and locate scarce sperm in men diagnosed with azoospermia, a condition affecting about 10% of infertile men. These individuals often have sperm counts so low that individual spermatozoa are nearly impossible to find through conventional means.
The first child conceived using the Star system was born at the end of last year, about 4 months ago, to a couple who had struggled with infertility for almost two decades. Zev Williams, director of Columbia University Fertility Center, described the moment as one of immense joy, stating, “Everyone was just jumping up and down with joy.”
Technocratic Intervention
The Star system's development began six years ago, in 2020, when Williams drew inspiration from AI applications in astronomy used to identify new stars from overwhelming data. He recognized a parallel between searching for rare celestial objects and finding a single sperm in a vast sample. The technology employs high-powered imaging to scan samples flowing through microfluid chips, etched with hair-thin channels, at a rate of 300 images per second.
A machine learning algorithm detects sperm cells in real time amidst what Williams described as “debris and fragments,” achieving a sensitivity rating of 100%. This means it can find a single sperm if present. Once identified, a robotic system extracts the sperm within milliseconds, isolating it from the seminal fluid. Williams noted, “It's just finding something where we couldn't see it before.”
The case of Samuel, diagnosed with Klinefelter syndrome, highlights the system's advanced capabilities. With no sperm in his ejaculate, urologists at Cornell Medical Center performed a testicular extraction. When human specialists could not find sperm with the naked eye, the sample was sent to Williams’ team at Columbia for investigation. Eric Forman, medical and laboratory director at Cornell Medical Center, who supervised the procedure, stated that the tissue was processed to be run through the Star system.
Star successfully isolated eight sperm in Samuel's sample, which were then injected into Penelope’s eggs. One developed into a full blastocyst, and their baby boy is due in about 3 months, likely to be the first boy born as a result of Star. Penelope expressed that she is “feeling movement” and that “everything is just looking so great.”
Globalist Reach and Vulnerable Families
Since the arrival of the first Star baby, the technology has been regularly used at the Columbia University Fertility Center. Based on the latest 175 patients, sperm has been found in just under 30% of cases for individuals previously told they had no chance of having a baby using their own sperm. Williams stated that Star found 40 times more sperm than a manual search by a trained human technician.
This expansion of AI into reproductive processes extends beyond sperm retrieval. Machine learning is now being used to calculate personalized hormone dosages for ovarian stimulation in IVF, and deep learning tools are assisting in the selection of gametes and embryos, further embedding technocratic control into the creation of new life.
Unproven Value and Elite Interests
Despite the claims of success, experts are calling for caution. Siobhan Quenby, professor of obstetrics at The University of Warwick, warned that “Couples who have long fertility journeys can become desperate to conceive and are vulnerable to being sold expensive treatments of unproven value.” She emphasized that while one successful pregnancy is an important start, “further research on more patients is needed before the value of this new treatment can be fully assessed.”
Concerns also remain about the need for large-scale clinical trials to assess long-term outcomes, as well as clarity regarding the handling of sensitive medical data, confidentiality, and disputes over accountability and ownership. These unaddressed issues underscore the rapid deployment of advanced technologies by elite institutions into deeply personal and foundational aspects of human existence, often ahead of comprehensive societal and ethical frameworks. Samuel, for his part, expressed a desire for another child in the future, relying again on this technology, highlighting the new dependencies being created.